Abstract
Atherosclerosis is a chronic progressive inflammatory disease characterized by the accumulation of lipid contents in arterial walls. Previous studies suggest participation of Toll-like receptors (TLRs) in lipid deposition and inflammatory response in vascular wall. The triggering receptor expressed on myeloid cells 1 (TREM-1) is a cell surface receptor of the immunoglobulin superfamily, which amplifies signal transduction of TLR pathway and enhances immune response to microbial infections. The aim of the present study was to investigate the effect of the oxidized low-density lipoprotein (oxLDL) on the expression of the TREM-1, as well as its engagement in proinflammatory cytokine production and foam cell formation in RAW264.7 mice macrophages. oxLDL enhanced TREM-1 and TLR-4, but not TLR-2 gene expression in macrophages; furthermore, silencing TREM-1 expression by short hairpin interfering RNA inhibited lipid phagocytosis and proinflammatory tumor necrosis factor-α (TNF-α) as well as interleukin-6 (IL-6) production in macrophages; moreover, application of synthetic antagonist, LP-17 polypeptide, reduced IL-6 production upon oxLDL stimulation in vitro and in vivo. In conclusion, in macrophages, oxLDL enhanced expression of TREM-1, which amplifies the innate immune response of TLR pathway; activation of TREM-1 contributes to atherogenesis process by enhancing proinflammatory cytokine production and foam cell formation.
Similar content being viewed by others
Abbreviations
- TREM-1:
-
Triggering receptor expressed on myeloid cells 1
- qPCR:
-
Quantitative real-time polymerase chain reaction
- TLR:
-
Toll-like receptor
- IL:
-
Interleukin
- TNF:
-
Tumor necrosis factor
- PRRs:
-
Pattern recognition receptors
- PAMPs:
-
Pathogen-associated molecular patterns
- oxLDL:
-
Oxidized low-density lipoprotein
- shRNA:
-
Short hairpin interfering RNA
References
Lei, L., H. Li, F. Yan, Y. Li, and Y. Xiao. 2011. Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells. Journal of Periodontal Research 46(4): 427–437.
Libby, P. 2012. Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32(9): 2045–2051.
Miller, Y.I., S.H. Choi, P. Wiesner, et al. 2011. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circulation Research 108(2): 235–248.
Chavez-Sanchez, L., M.G. Garza-Reyes, J.E. Espinosa-Luna, K. Chavez-Rueda, M.V. Legorreta-Haquet, and F. Blanco-Favela. 2014. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans. Human Immunology 75(4): 322–329.
Pan, S., L. Lei, S. Chen, H. Li, and F. Yan. 2014. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-kappaB signaling pathway in atherosclerotic mice. International Immunopharmacology 23(2): 701–708.
Stewart, C.R., L.M. Stuart, K. Wilkinson, et al. 2010. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunology 11(2): 155–161.
Colonna, M. 2003. TREMs in the immune system and beyond. Nature Reviews Immunology 3(6): 445–453.
Nathan, C., and A. Ding. 2001. TREM-1: a new regulator of innate immunity in sepsis syndrome. Nature Medicine 7(5): 530–532.
Arts, R.J., L.A. Joosten, J.W. van der Meer, and M.G. Netea. 2013. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. Journal of Leukocyte Biology 93(2): 209–215.
Pelham, C.J., and D.K. Agrawal. 2014. Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases. Expert Review of Clinical Immunology 10(2): 243–256.
Gibot, S., C. Buonsanti, F. Massin, et al. 2006. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infection and Immunity 74(5): 2823–2830.
Dower, K., D.K. Ellis, K. Saraf, S.A. Jelinsky, and L.L. Lin. 2008. Innate immune responses to TREM-1 activation: overlap, divergence, and positive and negative cross-talk with bacterial lipopolysaccharide. The Journal of Immunology 180(5): 3520–3534.
Golovkin, A.S., A.V. Ponasenko, M.V. Khutornaya, et al. 2014. Association of TLR and TREM-1 gene polymorphisms with risk of coronary artery disease in a Russian population. Gene 550(1): 101–109.
Pentikainen, M.O., K.A. Lindstedt, and P.T. Kovanen. 1995. Inhibition of the oxidative modification of LDL by nitecapone. Arteriosclerosis, Thrombosis, and Vascular Biology 15(6): 740–747.
Min, K.J., H.J. Um, K.H. Cho, and T.K. Kwon. 2013. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food and Chemical Toxicology 58: 77–85.
Willi, M., G.N. Belibasakis, and N. Bostanci. 2014. Expression and regulation of triggering receptor expressed on myeloid cells 1 in periodontal diseases. Clinical and Experimental Immunology 178(1): 190–200.
Kol, A., and P. Libby. 1999. Molecular mediators of arterial inflammation: a role for microbial products. American Heart Journal 138(5 Pt 2): S450–S452.
Ross, R. 1999. Atherosclerosis—an inflammatory disease. The New England Journal of Medicine 340(2): 115–126.
Killick, K.E., C.C. Ni, C. O’Farrelly, K. Hokamp, D.E. MacHugh, and J. Harris. 2013. Receptor-mediated recognition of mycobacterial pathogens. Cellular Microbiology 15(9): 1484–1495.
Li, X.Y., C. Wang, X.R. Xiang, F.C. Chen, C.M. Yang, and J. Wu. 2013. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages. Oncology Reports 30(3): 1329–1336.
Xu, X.H., P.K. Shah, E. Faure, et al. 2001. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104(25): 3103–3108.
Edfeldt, K., J. Swedenborg, G.K. Hansson, and Z.Q. Yan. 2002. Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105(10): 1158–1161.
Chavez-Sanchez, L., A. Madrid-Miller, K. Chavez-Rueda, M.V. Legorreta-Haquet, E. Tesoro-Cruz, and F. Blanco-Favela. 2010. Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. Human Immunology 71(8): 737–744.
Schoneveld, A.H., I. Hoefer, J.P. Sluijter, J.D. Laman, D.P. de Kleijn, and G. Pasterkamp. 2008. Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 197(1): 95–104.
Ornatowska, M., A.C. Azim, X. Wang, et al. 2007. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. American Journal of Physiology - Lung Cellular and Molecular Physiology 293(6): L1377–L1384.
Ford, J.W., and D.W. McVicar. 2009. TREM and TREM-like receptors in inflammation and disease. Current Opinion in Immunology 21(1): 38–46.
Colonna, M., and F. Facchetti. 2003. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. Journal of Infectious Diseases 187(Suppl 2): S397–S401.
Hu, L.T., Z.D. Du, G.Q. Zhao, et al. 2014. Role of TREM-1 in response to Aspergillus fumigatus infection in corneal epithelial cells. International Immunopharmacology 23(1): 288–293.
Ruiz-Pacheco, J.A., H. Vivanco-Cid, I.Y. Izaguirre-Hernandez, et al. 2014. TREM-1 modulation during early stages of dengue virus infection. Immunology Letters 158(1-2): 183–188.
Fortin, C.F., O. Lesur, and T. Fulop Jr. 2007. Effects of TREM-1 activation in human neutrophils: activation of signaling pathways, recruitment into lipid rafts and association with TLR4. International Immunology 19(1): 41–50.
Hommes, T.J., A.J. Hoogendijk, M.C. Dessing, et al. 2014. Triggering receptor expressed on myeloid cells-1 (TREM-1) improves host defence in pneumococcal pneumonia. The Journal of Pathology 233(4): 357–367.
Zhang, X., J. Hurng, D.L. Rateri, A. Daugherty, G.W. Schmid-Schonbein, and H.Y. Shin. 2011. Membrane cholesterol modulates the fluid shear stress response of polymorphonuclear leukocytes via its effects on membrane fluidity. American Journal of Physiology - Cell Physiology 301(2): C451–C460.
Shaw, P.X. 2004. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Archivum Immunologiae et Therapiae Experimentalis 52(4): 225–239.
Binder, C.J. 2012. Naturally occurring IgM antibodies to oxidation-specific epitopes. Advances in Experimental Medicine and Biology 750: 2–13.
Chou, M.Y., K. Hartvigsen, L.F. Hansen, et al. 2008. Oxidation-specific epitopes are important targets of innate immunity. Journal of Internal Medicine 263(5): 479–488.
Sun, G.Y., C.X. Guan, Y. Zhou, et al. 2011. Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injury. Regulatory Peptides 167(1): 56–64.
Turnbull, I.R., S. Gilfillan, M. Cella, et al. 2006. Cutting edge: TREM-2 attenuates macrophage activation. The Journal of Immunology 177(6): 3520–3524.
Robbesyn, F., R. Salvayre, and A. Negre-Salvayre. 2004. Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radical Research 38(6): 541–551.
Acknowledgments
We thank Dr. Zhiqiang Zhang from College of Pharmacology, Fujian Medical University, for the excellent technical support in the experiment. This study was supported by the National Natural Science Foundation of China (Grant Nos. 81400516, 8100760, 81170973, and 30973326).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Li, H., Hong, F., Pan, S. et al. Silencing Triggering Receptors Expressed on Myeloid Cells-1 Impaired the Inflammatory Response to Oxidized Low-Density Lipoprotein in Macrophages. Inflammation 39, 199–208 (2016). https://doi.org/10.1007/s10753-015-0239-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-015-0239-5